Sign in

Eduardo Argüelles-González

@eddargo.bsky.social
48 followers 92 following 31 posts

PhDc. Internist and Neurologist. Movement Disorders, Neurodegeneration and Neuromodulation. #MedEd | Tlönist, Ereignisnicht | www.parkinsoncdmx.com

PostsRepliesMedia
Eduardo Argüelles-González @eddargo.bsky.social · 06/01/2026
Centro de Trastornos del Movimiento y Neuromodulación del Hospital #MédicaSur | #DBS | #Parkinson youtube.com/watch?v=8oLL...
youtube.com
Centro de Trastornos del Movimiento del Hospital Médica Sur | DBS | Parkinson, Temblores y Distonía
YouTube video by Hospital Médica Sur
000
Eduardo Argüelles-González @eddargo.bsky.social · 20/03/2025
Immunomodulatory effects of invasive and non-invasive brain stimulation in #Parkinson's disease 🧠 #neuromodulation #neurology #movedisorder www.sciencedirect.com/science/arti...
010
Eduardo Argüelles-González @eddargo.bsky.social · 20/03/2025
Seeding amplification assay: Limitations and insights for enhanced clinical and research applications. 🧠 #Parkinson #movedisorder #neurology #MedEd journals.sagepub.com/doi/full/10....
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
010
Eduardo Argüelles-González @eddargo.bsky.social · 24/02/2025
Neuroimaging Techniques in #Huntington's Disease: A Critical Review 🧠 #Neurology #movedisorder #MedEd movementdisorders.onlinelibrary.wiley.com/doi/10.1002/...
movementdisorders.onlinelibrary.wiley.com
Neuroimaging Techniques in Huntington's Disease: A Critical Review
Background Huntington's disease (HD) is a hereditary neurodegenerative disorder characterized by cognitive, neuropsychiatric and motor symptoms caused by a CAG trinucleotide repeat expansion in the ...
032
Eduardo Argüelles-González @eddargo.bsky.social · 18/02/2025
Low‐Frequency Deep Brain Stimulation ( #DBS ) in Non‐Rapid Eye Movement Sleep Modifies Memory Retention in #Parkinson's Disease. 🧠 movementdisorders.onlinelibrary.wiley.com/doi/10.1002/... #neurology #movedisorder #MedEd
movementdisorders.onlinelibrary.wiley.com
Low‐Frequency Deep Brain Stimulation in Non‐Rapid Eye Movement Sleep Modifies Memory Retention in Parkinson's Disease
Background and Objective Memory impairment is a frequent and debilitating symptom in neurodegenerative disorders. The objective of this study was to provide proof-of-principle that deep brain stimul...
010
Eduardo Argüelles-González @eddargo.bsky.social · 17/02/2025
Systematic review and meta-analysis of repetitive transcranial magnetic stimulation (rTMS) for activities of daily living in #Alzheimer's disease 🧠 doi.org/10.1007/s100...
doi.org
Systematic review and meta-analysis of repetitive transcranial magnetic stimulation (rTMS) for activities of daily living in Alzheimer's disease - Neurological Sciences
Objective This systematic review of randomised controlled trials (RCTs) was conducted to assess the effect of repetitive transcranial magnetic stimulation (rTMS) on activities of daily living (ADLs) i...
000
Eduardo Argüelles-González @eddargo.bsky.social · 16/02/2025
Improving the Clinical Diagnostic Criteria for Genetically Confirmed Adult-Onset #Huntington Disease. 🧠 www.neurology.org/doi/full/10.... #Neurology #movedisorder
neurology.org
Improving the Clinical Diagnostic Criteria for Genetically Confirmed Adult-Onset Huntington Disease | Neurology Clinical Practice
BackgroundHuntington disease (HD) is a genetic neurodegenerative disorder. Given the focus on motor manifestations, nonmotor symptoms are frequently underappreciated in clinical evaluations, despite f...
000
Eduardo Argüelles-González @eddargo.bsky.social · 16/02/2025
GLP-1 receptor agonist for #Parkinson Disease. 🧠 www.prd-journal.com/article/S135...
prd-journal.com
GLP‐1 receptor agonists for Parkinson's disease: An updated meta-analysis
Treatments for Parkinson's disease (PD) focus on symptom reduction through dopaminergic therapies, without clear evidence of disease-modifying effects. Glucagon-like peptide-1 (GLP-1) receptor agonist...
000
Eduardo Argüelles-González @eddargo.bsky.social · 10/02/2025
Movement Disorders after Dengue Virus Infection: A Scoping Review. 🧠🦟 movementdisorders.onlinelibrary.wiley.com/doi/abs/10.1...
movementdisorders.onlinelibrary.wiley.com
Movement Disorders after Dengue Virus Infection: A Scoping Review
Movement disorders after dengue virus (DENV) infection have been increasingly recognized. We aimed to synthesize the clinical and paraclinical characteristics, treatment responses, and outcomes of th...
000
Eduardo Argüelles-González @eddargo.bsky.social · 10/02/2025
Aging, cellular senescence and #Parkinson's disease🧠 journals.sagepub.com/doi/full/10....
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
010
Eduardo Argüelles-González @eddargo.bsky.social · 08/02/2025
000
Eduardo Argüelles-González @eddargo.bsky.social · 07/02/2025
Muy feliz de formar parte de este equipo! youtube.com/watch?v=uUJ9...
youtube.com
000
Eduardo Argüelles-González @eddargo.bsky.social · 06/02/2025
Atlas of the plasma proteome in health and disease in 53,026 adults. www.cell.com/cell/fulltex...
cell.com
Atlas of the plasma proteome in health and disease in 53,026 adults
A large-scale proteomics study involving 53,026 individuals maps 2,920 plasma proteins to 406 prevalent diseases, 660 incident diseases, and 986 health-related traits, identifying promising biomarkers...
000
Eduardo Argüelles-González @eddargo.bsky.social · 29/01/2025
☕️🧠
000
Eduardo Argüelles-González @eddargo.bsky.social · 19/01/2025
Procesos y momentos de la investigación en los posgrados de educación 📚 shorturl.at/GmkZV
000
Eduardo Argüelles-González @eddargo.bsky.social · 02/01/2025
Let’s kick off the year with some academic humor🧠 #medEd #medicine #neurology #academia
000
Eduardo Argüelles-González @eddargo.bsky.social · 23/12/2024
Commercial symptom monitoring devices in #Parkinson’s disease: benefits, limitations, and trends. 🧠 www.frontiersin.org/journals/neu...
frontiersin.org
Frontiers | Commercial symptom monitoring devices in Parkinson’s disease: benefits, limitations, and trends
010
Eduardo Argüelles-González @eddargo.bsky.social · 23/12/2024
Lewy body co‐pathology in #Alzheimer's disease and primary age‐related tauopathy contributes to differential neuropathological, cognitive, and brain atrophy patterns. 🧠 alz-journals.onlinelibrary.wiley.com/doi/10.1002/...
alz-journals.onlinelibrary.wiley.com
Lewy body co‐pathology in Alzheimer's disease and primary age‐related tauopathy contributes to differential neuropathological, cognitive, and brain atrophy patterns
INTRODUCTION Alzheimer's disease (AD) co-pathology with Lewy bodies (LB) is frequent and influences clinical manifestations and outcomes. Its significance in primary age-related tauopathy (PART) is ...
010
Eduardo Argüelles-González @eddargo.bsky.social · 22/12/2024
Near future academic publishing – a speculative social science fiction experiment. www.tandfonline.com/doi/full/10....
tandfonline.com
Near future academic publishing – a speculative social science fiction experiment
Published in Learning, Media and Technology (Vol. 49, No. 4, 2024)
010
Eduardo Argüelles-González @eddargo.bsky.social · 22/12/2024
Gastrointestinal Dysfunction Bears on the Clinical‐Biological Profile of #Parkinson's Disease. 🧠 movementdisorders.onlinelibrary.wiley.com/doi/10.1002/...
movementdisorders.onlinelibrary.wiley.com
Gastrointestinal Dysfunction Bears on the Clinical‐Biological Profile of Parkinson's Disease
Background Gastrointestinal dysfunction (GID) accompanies any phase of Parkinson's disease (PD), underlying differential clinical-pathological trajectories. Objective To investigate associations b...
010
Eduardo Argüelles-González @eddargo.bsky.social · 21/12/2024
(Perhaps) the last of the year.
010
Eduardo Argüelles-González @eddargo.bsky.social · 19/12/2024
CSF-αSyn-SAA reveals amplification differences among #Parkinson’s subtypes (e.g., LRRK2 vs. GBA), but overlaps limit individual utility. Not clear enough if these parameters represent true markers of pathology or simply phenotypic variability movementdisorders.onlinelibrary.wiley.com/doi/10.1002/...
movementdisorders.onlinelibrary.wiley.com
Association between the Amplification Parameters of the α‐Synuclein Seed Amplification Assay and Clinical and Genetic Subtypes of Parkinson's Disease
Background α-Synuclein seed amplification assay on cerebrospinal fluid (CSF-αSyn-SAA) has shown high accuracy for Parkinson's disease (PD) diagnosis. The analysis of CSF-αSyn-SAA parameters may prov...
010
Eduardo Argüelles-González @eddargo.bsky.social · 19/12/2024
#DBS in #Parkinson: only 23-30% of patients are women. Why? Less support, fear of risks, and lack of tailored information. We need to break barriers with targeted support networks and education. Equity in healthcare matters. 🧠 movementdisorders.onlinelibrary.wiley.com/doi/10.1002/...
movementdisorders.onlinelibrary.wiley.com
How Women and Men with Parkinson's Disease Approach Decision‐Making for Deep Brain Stimulation Surgery
Background Women make up only 23% to 30% of recipients for deep brain stimulation (DBS) surgery for Parkinson's disease (PD), a discrepancy that is not accounted for by differences in disease incide.....
010
Eduardo Argüelles-González @eddargo.bsky.social · 15/12/2024
¿Cómo se repone uno de esto? #cartarescu
120
Eduardo Argüelles-González @eddargo.bsky.social · 12/12/2024
Increases in amyloid-β42 slow cognitive and clinical decline in #Alzheimer ´s disease trials 🧠 academic.oup.com/brain/articl... #Neurology #dementia #ClinicalTrials
academic.oup.com
Increases in amyloid-β42 slow cognitive and clinical decline in Alzheimer’s disease trials
By analysing data from over 25 000 patients with Alzheimer’s disease in 24 randomized controlled trials, Abanto et al. show that the cognitive improvements
020
Eduardo Argüelles-González @eddargo.bsky.social · 11/12/2024
Movement disorders in #opioid users observed in the social networks: a systematic review. #movedisorder #fentanyl #Neurology 🧠 www.scielo.org.mx/pdf/rmn/v25n...
010
Eduardo Argüelles-González @eddargo.bsky.social · 07/12/2024
Testing theory of #mind in large language models and humans. rdcu.be/d2IZD #neurology #ai #behavior
rdcu.be
Testing theory of mind in large language models and humans
Nature Human Behaviour - Testing two families of large language models (LLMs) (GPT and LLaMA2) on a battery of measurements spanning different theory of mind abilities, Strachan et al. find that...
010
Eduardo Argüelles-González @eddargo.bsky.social · 06/12/2024
"An ancient foe within neurosciences education". 👉🏻 www.revmexneurociencia.com/frame_eng.ph... #MedEd #Neurology #neuroscience
020
Eduardo Argüelles-González @eddargo.bsky.social · 30/11/2024
Congreso Nacional de Medicina Interna. @CMIMorg #Neurology #internalmedicine
010
Eduardo Argüelles-González @eddargo.bsky.social · 22/11/2024
Viena.
000